John de Kruif
Chief Tech/Sci/R&D Officer bei MERUS N.V.
Aktive Positionen von John de Kruif
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MERUS N.V. | Chief Tech/Sci/R&D Officer | 01.04.2007 | - |
Karriereverlauf von John de Kruif
Ehemalige bekannte Positionen von John de Kruif
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Corporate Officer/Principal | 01.10.2000 | 01.10.2006 |
Ausbildung von John de Kruif
University of Utrecht | Doctorate Degree |
Statistik
International
Niederlande | 4 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Doctorate Degree | 1 |
Sektoral
Health Technology | 3 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MERUS N.V. | Health Technology |
Private Unternehmen | 1 |
---|---|
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
- Börse
- Insiders
- John de Kruif
- Erfahrung